Thrombin

Molecular Aspects of Medicine

Volumn 29, Issue 4, 2008, Pages 203-254

  Di Cera, Enrico ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allostery; Na+ activation; PARs; Thrombin

Indexed keywords

SODIUM ION; THROMBIN; THROMBOMODULIN;

ANTICOAGULATION; BLOOD CLOTTING; ENZYME KINETICS; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; REVIEW;

ALLOSTERIC REGULATION; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; HUMANS; THROMBIN;

EID: 43449133549     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2008.01.001     Document Type: Review

References (249)

1. Adema C.M., Hertel L.A., Miller R.D., and Loker E.S. A family of fibrinogen-related proteins that precipitates parasite-derived molecules is produced by an invertebrate after infection. Proc. Natl. Acad. Sci. USA 94 (1997) 8691-8696
2. Adrogue H.J., and Madias N.E. Hypernatremia. New Engl. J. Med. 342 (2000) 1493-1499
3. Adrogue H.J., and Madias N.E. Hyponatremia. New Engl. J. Med. 342 (2000) 1581-1589
4. Akhavan S., Rocha E., Zeinali S., and Mannucci P.M. Gly319 → arg substitution in the dysfunctional prothrombin Segovia. Br. J. Haematol. 105 (1999) 667-669
5. Akhavan S., Mannucci P.M., Lak M., Mancuso G., Mazzucconi M.G., Rocino A., Jenkins P.V., and Perkins S.J. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb. Haemost. 84 (2000) 989-997
6. Armstrong R.N. Mechanistic diversity in a metalloenzyme superfamily. Biochemistry 39 (2000) 13625-13632
7. Arosio D., Ayala Y.M., and Di Cera E. Mutation of W215 compromises thrombin cleavage of fibrinogen, but not of PAR-1 or protein C. Biochemistry 39 (2000) 8095-8101
8. Ayala Y., and Di Cera E. Molecular recognition by thrombin. Role of the slow → fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components. J. Mol. Biol. 235 (1994) 733-746
9. Ayala Y.M., and Di Cera E. A simple method for the determination of individual rate constants for substrate hydrolysis by serine proteases. Protein Sci. 9 (2000) 1589-1593
10. Ayala Y.M., Vindigni A., Nayal M., Spolar R.S., Record Jr. M.T., and Di Cera E. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding. J. Mol. Biol. 253 (1995) 787-798
11. Ayala Y.M., Cantwell A.M., Rose T., Bush L.A., Arosio D., and Di Cera E. Molecular mapping of thrombin-receptor interactions. Proteins 45 (2001) 107-116
12. Bae J.S., Yang L., Manithody C., and Rezaie A.R. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 110 (2007) 3909-3916
13. Bae J.S., Yang L., and Rezaie A.R. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc. Natl. Acad. Sci. USA 104 (2007) 2867-2872
14. Baglin T.P., Carrell R.W., Church F.C., Esmon C.T., and Huntington J.A. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl. Acad. Sci. USA 99 (2002) 11079-11084
15. + binding to thrombin. J. Biol. Chem. 281 (2006) 40049-40056
16. Bah A., Chen Z., Bush-Pelc L.A., Mathews F.S., and Di Cera E. Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4. Proc. Natl. Acad. Sci. USA 104 (2007) 11603-11608
17. 2+ sites in factor VIIa. J. Biol. Chem. 281 (2006) 24873-24888
18. Bajzar L., Morser J., and Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271 (1996) 16603-16608
19. Banfield D.K., and MacGillivray R.T. Partial characterization of vertebrate prothrombin cDNAs: amplification and sequence analysis of the B chain of thrombin from nine different species. Proc. Natl. Acad. Sci. USA 89 (1992) 2779-2783
20. Bar-Shavit R., Kahn A., Wilner G.D., and Fenton II J.W. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science 220 (1983) 728-731
21. Bar-Shavit R., Sabbah V., Lampugnani M.G., Marchisio P.C., Fenton II J.W., Vlodavsky I., and Dejana E. An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J. Cell Biol. 112 (1991) 335-344
22. Bartunik H.D., Summers L.J., and Bartsch H.H. Crystal structure of bovine beta-trypsin at 1.5. A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. J. Mol. Biol. 210 (1989) 813-828
23. Bates S.M., and Weitz J.I. The status of new anticoagulants. Br. J. Haematol. 134 (2006) 3-19
24. Berg D.T., Wiley M.R., and Grinnell B.W. Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator. Science 273 (1996) 1389-1391
25. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterbrand J.D., Ely E.W., et al. Recombinant human protein C worldwide evaluation in severe sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. New Engl. J. Med. 344 (2001) 699-709
26. Berny M.A., White T.C., Tucker E.I., Bush-Pelc L.A., Di Cera E., Gruber A., and McCarty O.J. Thrombin mutant W215A/E217A acts as a platelet GpIb antagonist. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 329-334
27. Bobofchak K.M., Pineda A.O., Mathews F.S., and Di Cera E. Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases. J. Biol. Chem. 280 (2005) 25644-25650
28. Bode W. Structure and interaction modes of thrombin. Blood Cells Mol. Dis. 36 (2006) 122-130
29. Bode W., Turk D., and Karshikov A. The refined 1.9-A X-ray crystal structure of d-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1 (1992) 426-471
30. Bone S. Dielectric studies of water clusters in cyclodextrins: relevance to the transition between slow and fast forms of thrombin. J. Phys. Chem. B Condens. Matter Mater. Surf. Interfaces Biophys. 110 (2006) 20609-20614
31. Botts J., and Morales M. Analytical description of the effects of modifiers and of multivalency upon the steady state catalyzed reaction rate. Trans. Faraday Soc. 49 (1953) 696-707
32. Boyer P.D., Lardy H.A., and Phillips P.H. The role of potassium in muscle phosphorylations. J. Biol. Chem. 146 (1942) 673-681
33. Brass L.F. Thrombin and platelet activation. Chest 124 (2003) 18S-25S
34. + activation but retains high catalytic activity. J. Biol. Chem. 281 (2006) 7183-7188
35. Camire R.M. Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site. J. Biol. Chem. 277 (2002) 37863-37870
36. Cantwell A.M., and Di Cera E. Rational design of a potent anticoagulant thrombin. J. Biol. Chem. 275 (2000) 39827-39830
37. + reveal the basis of monovalent cation selectivity and an inactive slow form. Biophys. Chem. 121 (2006) 177-184
38. Carter W.J., Myles T., Gibbs C.S., Leung L.L., and Huntington J.A. Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. J. Biol. Chem. 279 (2004) 26387-26394
39. Carter W.J., Cama E., and Huntington J.A. Crystal structure of thrombin bound to heparin. J. Biol. Chem. 280 (2005) 2745-2749
40. Castagnetto J.M., Hennessy S.W., Roberts V.A., Getzoff E.D., Tainer J.A., and Pique M.E. MDB: the metalloprotein database and browser at the Scripps Research Institute. Nucleic Acids Res. 30 (2002) 379-382
41. Celikel R., McClintock R.A., Roberts J.R., Mendolicchio G.L., Ware J., Varughese K.I., and Ruggeri Z.M. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science 301 (2003) 218-221
42. Clackson T., and Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science 267 (1995) 383-386
43. Cleary D.B., Trumbo T.A., and Maurer M.C. Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface. Arch. Biochem. Biophys. 403 (2002) 179-188
44. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
45. Cohn M., and Monod J. Purification and properties of the beta-galactosidase (lactase) of Escherichia coli. Biochim. Biophys. Acta 7 (1951) 153-174
46. Colwell N.S., Blinder M.A., Tsiang M., Gibbs C.S., Bock P.E., and Tollefsen D.M. Allosteric effects of a monoclonal antibody against thrombin exosite II. Biochemistry 37 (1998) 15057-15065
47. Coughlin S.R. Thrombin signalling and protease-activated receptors. Nature 407 (2000) 258-264
48. Curragh E.F., and Elmore D.T. Kinetics and mechanism of catalytic of proteolytic enzymes. Biochem. J. 93 (1964) 163-171
49. Dang Q.D., and Di Cera E. Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases. Proc. Natl. Acad. Sci. USA 93 (1996) 10653-10656
50. Dang O.D., Vindigni A., and Di Cera E. An allosteric switch controls the procoagulant and anticoagulant activities of thrombin. Proc. Natl. Acad. Sci. USA 92 (1995) 5977-5981
51. Dang Q.D., Guinto E.R., and Di Cera E. Rational engineering of activity and specificity in a serine protease. Nat. Biotechnol. 15 (1997) 146-149
52. Dang Q.D., Sabetta M., and Di Cera E. Selective loss of fibrinogen clotting in a loop-less thrombin. J. Biol. Chem. 272 (1997) 19649-19651
53. Davie E.W., and Kulman J.D. An overview of the structure and function of thrombin. Semin. Thromb. Hemost. 32 Suppl 1 (2006) 3-15
54. De Cristofaro R., De Candia E., Rutella S., and Weitz J.I. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. J. Biol. Chem. 275 (2000) 3887-3895
55. De Cristofaro R., Akhavan S., Altomare C., Carotti A., Peyvandi F., and Mannucci P.M. A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human {alpha}-thrombin. J. Biol. Chem. (2004) 13035-13043 %R 10.1074/jbc.M312430200
56. + binding. FEBS J. 273 (2006) 159-169
57. + binding on the conformation, stability and molecular recognition properties of thrombin. Biochem. J. 390 (2005) 485-492
58. Degen S.J., McDowell S.A., Sparks L.M., and Scharrer I. Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala. Thromb. Haemost. 73 (1995) 203-209
59. Dementiev A., Petitou M., Herbert J.M., and Gettins P.G. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity. Nat. Struct. Mol. Biol. 11 (2004) 863-867
60. de Wardener H.E. The hypothalamus and hypertension. Physiol. Rev. 81 (2001) 1599-1658
61. DiBella E.E., Maurer M.C., and Scheraga H.A. Expression and folding of recombinant bovine prethrombin-2 and its activation to thrombin. J. Biol. Chem. 270 (1995) 163-169
62. Di Cera E. Thermodynamic Theory of Site-Specific Binding Processes in Biological Macromolecules (1995), Cambridge University Press, Cambridge, UK
63. Di Cera E. Thrombin interactions. Chest 124 (2003) 11S-17S
64. Di Cera E. A structural perspective on enzymes activated by monovalent cations. J. Biol. Chem. 281 (2006) 1305-1308
65. Di Cera E. Thrombin as procoagulant and anticoagulant. J. Thromb. Haemost. 5 (2007) 196-202
66. + binding site of thrombin. J. Biol. Chem. 270 (1995) 22089-22092
67. Di Cera E., Hopfner K.P., and Dang Q.D. Theory of allosteric effects in serine proteases. Biophys. J. 70 (1996) 174-181
68. Di Cera E., Dang Q.D., and Ayala Y.M. Molecular mechanisms of thrombin function. Cell Mol. Life Sci. 53 (1997) 701-730
69. Di Cera E., Page M.J., Bah A., Bush-Pelc L.A., and Garvey L.C. Thrombin allostery. Phys. Chem. Chem. Phys. 9 (2007) 1292-1306
70. Dihanich M., Kaser M., Reinhard E., Cunningham D., and Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6 (1991) 575-581
71. + conduction and selectivity. Science 280 (1998) 69-77
72. Dumas J.J., Kumar R., Seehra J., Somers W.S., and Mosyak L. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science 301 (2003) 222-226
73. Eisenman G., and Dani J.A. An introduction to molecular architecture and permeability of ion channels. Annu. Rev. Biophys. Biophys. Chem. 16 (1987) 205-226
74. Esmon C.T. Inflammation and thrombosis. J. Thromb. Haemost. 1 (2003) 1343-1348
75. Esmon C.T. The protein C pathway. Chest 124 (2003) 26S-32S
76. Esmon C.T., and Mather T. Switching serine protease specificity. Nat. Struct. Biol. 5 (1998) 933-937
77. Esmon N.L., DeBault L.E., and Esmon C.T. Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C. J. Biol. Chem. 258 (1983) 5548-5553
78. Esmon C.T., Xu J., Gu J.M., Qu D., Laszik Z., Ferrell G., Stearns-Kurosawa D.J., Kurosawa S., Taylor Jr. F.B., and Esmon N.L. Endothelial protein C receptor. Thromb. Haemost. 82 (1999) 251-258
79. Feistritzer C., Schuepbach R.A., Mosnier L.O., Bush L.A., Di Cera E., Griffin J.H., and Riewald M. Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells. J. Biol. Chem. 281 (2006) 20077-20084
80. Finney L.A., and O'Halloran T.V. Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science 300 (2003) 931-936
81. Frohlich E.D., and Varagic J. The role of sodium in hypertension is more complex than simply elevating arterial pressure. Nat. Clin. Pract. Cardiovasc. Med. 1 (2004) 24-30
82. Fuentes-Prior P., Iwanaga Y., Huber R., Pagila R., Rumennik G., Seto M., Morser J., Light D.R., and Bode W. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 404 (2000) 518-525
83. Fuhrmann C.N., Daugherty M.D., and Agard D.A. Subangstrom crystallography reveals that short ionic hydrogen bonds, and not a His-Asp low-barrier hydrogen bond, stabilize the transition state in serine protease catalysis. J. Am. Chem. Soc. 128 (2006) 9086-9102
84. Gailani D., and Broze Jr. G.J. Factor XI activation in a revised model of blood coagulation. Science 253 (1991) 909-912
85. Gandhi P.S., Chen Z., Mathews F.S., and Di Cera E. Structural identification of the pathway of long-range communication in an allosteric enzyme. Proc. Natl. Acad. Sci. USA 105 (2008) 1832-1837
86. Gan Z.R., Li Y., Chen Z., Lewis S.D., and Shafer J.A. Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J. Biol. Chem. 269 (1994) 1301-1305
87. Gettins P.G. Serpin structure, mechanism, and function. Chem. Rev. 102 (2002) 4751-4804
88. + binding to thrombin resolved by ultra-rapid kinetics. Biophys. Chem. 131 (2007) 111-114
89. Gibbs C.S., Coutre S.E., Tsiang M., Li W.X., Jain A.K., Dunn K.E., Law V.S., Mao C.T., Matsumura S.Y., Mejza S.J., et al. Conversion of thrombin into an anticoagulant by protein engineering. Nature 378 (1995) 413-416
90. Girard T.J., MacPhail L.A., Likert K.M., Novotny W.F., Miletich J.P., and Broze Jr. G.J. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein. Science 248 (1990) 1421-1424
91. Goldman J.A., and Eckerling B. Intracranial dural sinus thrombosis following intrauterine instillation of hypertonic saline. Am. J. Obstet. Gynecol. 112 (1972) 1132-1133
92. Gopalakrishna K., and Rezaie A.R. The influence of sodium ion binding on factor IXa activity. Thromb. Haemost. 95 (2006) 936-941
93. Grant P.J., Tate G.M., Hughes J.R., Davies J.A., and Prentice C.R. Does hypernatremia promote thrombosis?. Thromb. Res. 40 (1985) 393-399
94. Greenspan N.S., and Di Cera E. Defining epitopes: it is not as easy as it seems. Nat. Biotechnol. 17 (1999) 936-937
95. Griffin J.H. Blood coagulation. The thrombin paradox. Nature 378 (1995) 337-338
96. Griffin J.H., Zlokovic B., and Fernandez J.A. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin. Hematol. 39 (2002) 197-205
97. + binding to coagulation serine proteases. Biophys. Chem. 90 (2001) 89-96
98. Grinnell B.W., Gerlitz B., and Berg D.T. Identification of a region in protein C involved in thrombomodulin-stimulated activation by thrombin: potential repulsion at anion-binding site I in thrombin. Biochem. J. 303 Pt 3 (1994) 929-933
99. Gruber A., Griffin J.H., Harker L.A., and Hanson S.R. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 73 (1989) 639-642
100. Gruber A., Hanson S.R., Kelly A.B., Yan B.S., Bang N., Griffin J.H., and Harker L.A. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation 82 (1990) 578-585
101. Gruber A., Cantwell A.M., Di Cera E., and Hanson S.R. The thrombin mutant W215A/E217A shows safe and potent anticoagulant and antithrombotic effects in vivo. J. Biol. Chem. 277 (2002) 27581-27584
102. Gruber A., Fernandez J.A., Bush L., Marzec U., Griffin J.H., Hanson S.R., and Di Cera E. Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates. J. Thromb. Haemost. 4 (2006) 392-397
103. Gruber A., Marzec U.M., Bush L., Di Cera E., Fernandez J.A., Berny M.A., Tucker E.I., McCarty O.J., Griffin J.H., and Hanson S.R. Relative antithrombotic and antihemostatic effects of protein C activator versus low molecular weight heparin in primates. Blood 109 (2007) 3733-3740
104. Guinto E.R., and Di Cera E. Large heat capacity change in a protein-monovalent cation interaction. Biochemistry 35 (1996) 8800-8804
105. Guinto E.R., Caccia S., Rose T., Futterer K., Waksman G., and Di Cera E. Unexpected crucial role of residue 225 in serine proteases. Proc. Natl. Acad. Sci. USA 96 (1999) 1852-1857
106. Hageman T.C., Endres G.F., and Scheraga H.A. Mechanism of action of thrombin on fibrinogen. On the role of the A chain of bovine thrombin in specificity and in differentiating between thrombin and trypsin. Arch. Biochem. Biophys. 171 (1975) 327-336
107. Hall S.W., Nagashima M., Zhao L., Morser J., and Leung L.L. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. J. Biol. Chem. 274 (1999) 25510-25516
108. Hanson S.R., Griffin J.H., Harker L.A., Kelly A.B., Esmon C.T., and Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J. Clin. Invest. 92 (1993) 2003-2012
109. He X., and Rezaie A.R. Identification and characterization of the sodium-binding site of activated protein C. J. Biol. Chem. 274 (1999) 4970-4976
110. Hedstrom L. Serine protease mechanism and specificity. Chem. Rev. 102 (2002) 4501-4524
111. Hedstrom L., Szilagyi L., and Rutter W.J. Converting trypsin to chymotrypsin: the role of surface loops. Science 255 (1992) 1249-1253
112. Henriksen R.A., Dunham C.K., Miller L.D., Casey J.T., Menke J.B., Knupp C.L., and Usala S.J. Prothrombin Greenville, Arg517 → Gln, identified in an individual heterozygous for dysprothrombinemia. Blood 91 (1998) 2026-2031
113. Hill T.L. Free Energy Transduction in Biology (1977), Academic Press, New York, NY
114. Hofsteenge J., Braun P.J., and Stone S.R. Enzymatic properties of proteolytic derivatives of human alpha-thrombin. Biochemistry 27 (1988) 2144-2151
115. Huntington J.A., and Esmon C.T. The molecular basis of thrombin allostery revealed by a 1.8 a structure of the "Slow" form. Structure (Camb) 11 (2003) 469-479
116. Ibers J.A., and Holm R.H. Modeling coordination sites in metallobiomolecules. Science 209 (1980) 223-235
117. Ishihara H., Connolly A.J., Zeng D., Kahn M.L., Zheng Y.W., Timmons C., Tram T., and Coughlin S.R. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386 (1997) 502-506
118. Jacques S.L., and Kuliopulos A. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. Biochem. J. 376 (2003) 733-740
119. +-free state. Biochem. J. 392 (2005) 21-28
120. Kabsch W., Mannherz H.G., Suck D., Pai E.F., and Holmes K.C. Atomic structure of the actin:DNase I complex. Nature 347 (1990) 37-44
121. Kachmar J.F., and Boyer P.D. Kinetic analysis of enzyme reactions. II. The potassium activation and calcium inhibition of pyruvic phosphoferase. J. Biol. Chem. 200 (1953) 669-682
122. Kahn M.L., Zheng Y.W., Huang W., Bigornia V., Zeng D., Moff S., Farese Jr. R.V., Tam C., and Coughlin S.R. A dual thrombin receptor system for platelet activation. Nature 394 (1998) 690-694
123. Kamata K., Mitsuya M., Nishimura T., Eiki J., and Nagata Y. Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure 12 (2004) 429-438
124. Kezdy F.J., Lorand L., and Miller K.D. Titration of active centers in thrombin solutions. Standardization of the enzyme. Biochemistry 4 (1965) 2302-2308
125. + binding. Proteins 30 (1998) 34-42
126. Krem M.M., and Di Cera E. Molecular markers of serine protease evolution. EMBO J. 20 (2001) 3036-3045
127. Krem M.M., and Di Cera E. Evolution of enzyme cascades from embryonic development to blood coagulation. Trends Biochem. Sci. 27 (2002) 67-74
128. Krem M.M., Rose T., and Di Cera E. The C-terminal sequence encodes function in serine proteases. J. Biol. Chem. 274 (1999) 28063-28066
129. Krem M.M., Prasad S., and Di Cera E. Ser(214) is crucial for substrate binding to serine proteases. J. Biol. Chem. 277 (2002) 40260-40264
130. Kroh H.K., Tans G., Nicolaes G.A.F., Rosing J., and Bock P.E. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation. J. Biol. Chem. 282 (2007) 16095-16104
131. Kurlansky M. Salt: A World History (2002), Random House Publishing Limited, Toronto, Canada p. 484
132. Lai M.T., Di Cera E., and Shafer J.A. Kinetic pathway for the slow to fast transition of thrombin. Evidence of linked ligand binding at structurally distinct domains. J. Biol. Chem. 272 (1997) 30275-30282
133. Laughlin L.T., and Reed G.H. The monovalent cation requirement of rabbit muscle pyruvate kinase is eliminated by substitution of lysine for glutamate 117. Arch. Biochem. Biophys. 348 (1997) 262-267
134. Le Bonniec B.F., and Esmon C.T. Glu-192-Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc. Natl. Acad. Sci. USA 88 (1991) 7371-7375
135. Lefkowitz J.B., Haver T., Clarke S., Jacobson L., Weller A., Nuss R., Manco-Johnson M., and Hathaway W.E. The prothrombin Denver patient has two different prothrombin point mutations resulting in Glu-300 → Lys and Glu-309 → Lys substitutions. Br. J. Haematol. 108 (2000) 182-187
136. Levigne S., Thiec F., Cherel S., Irving J.A., Fribourg C., and Christophe O.D. Role of the alpha-helix 163-170 in factor Xa catalytic activity. J. Biol. Chem. 282 (2007) 31569-31579
137. Li W., Johnson D.J., Esmon C.T., and Huntington J.A. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat. Struct. Mol. Biol. 11 (2004) 857-862
138. Liu L.W., Vu T.K., Esmon C.T., and Coughlin S.R. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J. Biol. Chem. 266 (1991) 16977-16980
139. Lorand L., Brannen Jr. W.T., and Rule N.G. Thrombin-catalyzed hydrolysis of p-nitrophenyl esters. Arch. Biochem. Biophys. 96 (1962) 147-151
140. Lorand L., Downey J., Gotoh T., Jacobsen A., and Tokura S. The transpeptidase system which crosslinks fibrin by gamma-glutamyle-epsilon-lysine bonds. Biochem. Biophys. Res. Commun. 31 (1968) 222-230
141. Malkowski M.G., Martin P.D., Guzik J.C., and Edwards B.F.P. The co-crystal structure of unliganded bovine {alpha}-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding. Protein Sci. 6 (1997) 1438-1448
142. Mann K.G. Thrombin formation. Chest 124 (2003) 4S-10S
143. Mann K.G., Butenas S., and Brummel K. The dynamics of thrombin formation. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 17-25
144. + activation mimicry in murine thrombin. J. Biol. Chem. 282 (2007) 16355-16361
145. Martin C.J., Golubow J., and Axelrod A.E. The hydrolysis of carbobenzoxy-l-tyrosine p-nitrophenyl ester by various enzymes. J. Biol. Chem. 234 (1959) 1718-1725
146. Mathews I.I., Padmanabhan K.P., Ganesh V., Tulinsky A., Ishii M., Chen J., Turck C.W., Coughlin S.R., and Fenton II J.W. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry 33 (1994) 3266-3279
147. McLaughlin J.N., Patterson M.M., and Malik A.B. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc. Natl. Acad. Sci. USA 104 (2007) 5662-5667
148. Meneton P., Jeunemaitre X., de Wardener H.E., and MacGregor G.A. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol. Rev. 85 (2005) 679-715
149. Mengwasser K.E., Bush L.A., Shih P., Cantwell A.M., and Di Cera E. Hirudin binding reveals key determinants of thrombin allostery. J. Biol. Chem. 280 (2005) 23997-27003
150. Miyata T., Aruga R., Umeyama H., Bezeaud A., Guillin M.C., and Iwanaga S. Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. Biochemistry 31 (1992) 7457-7462
151. Monnaie D., Arosio D., Griffon N., Rose T., Rezaie A.R., and Di Cera E. Identification of a binding site for quaternary amines in factor Xa. Biochemistry 39 (2000) 5349-5354
152. Myles T., Le Bonniec B.F., and Stone S.R. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1. Eur. J. Biochem. 268 (2001) 70-77
153. Myles T., Yun T.H., Hall S.W., and Leung L.L. An extensive interaction interface between thrombin and factor V is required for factor V activation. J. Biol. Chem. 276 (2001) 25143-25149
154. Nakanishi-Matsui M., Zheng Y.W., Sulciner D.J., Weiss E.J., Ludeman M.J., and Coughlin S.R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404 (2000) 609-613
155. Nogami K., Zhou Q., Myles T., Leung L.L., Wakabayashi H., and Fay P.J. Exosite-interactive regions in the A1 and A2 domains of factor VIII facilitate thrombin-catalyzed cleavage of heavy chain. J. Biol. Chem. 280 (2005) 18476-18487
156. O'Brien M.C., and McKay D.B. How potassium affects the activity of the molecular chaperone Hsc70. I. Potassium is required for optimal ATPase activity. J. Biol. Chem. 270 (1995) 2247-2250
157. O'Brien P.J., Molino M., Kahn M., and Brass L.F. Protease activated receptors: theme and variations. Oncogene 20 (2001) 1570-1581
158. Olson S.T., and Chuang Y.J. Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases. Trends. Cardiovasc. Med. 12 (2002) 331-338
159. Orthner C.L., and Kosow D.P. The effect of metal ions on the amidolytic activity of human factor Xa (activated Stuart-Prower factor). Arch. Biochem. Biophys. 185 (1978) 400-406
160. Orthner C.L., and Kosow D.P. Evidence that human alpha-thrombin is a monovalent cation-activated enzyme. Arch. Biochem. Biophys. 202 (1980) 63-75
161. + in enzyme function. Physiol. Rev. 86 (2006) 1049-1092
162. Page, M.J., Di Cera, E., 2008. Serine peptidases: classification, structure and function. Cell Mol. Life Sci., in press.
163. Page M.J., MacGillivray R.T.A., and Di Cera E. Determinants of specificity in coagulation proteases. J. Thromb. Haemost. 3 (2005) 2401-2408
164. Papaconstantinou M.E., Carrell C.J., Pineda A.O., Bobofchak K.M., Mathews F.S., Flordellis C.S., Maragoudakis M.E., Tsopanoglou N.E., and Di Cera E. Thrombin functions through its RGD sequence in a non-canonical conformation. J. Biol. Chem. 280 (2005) 29393-29396
165. Parry M.A., Stone S.R., Hofsteenge J., and Jackman M.P. Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem. J. 290 Pt 3 (1993) 665-670
166. Pechik I., Madrazo J., Mosesson M.W., Hernandez I., Gilliland G.L., and Medved L. Crystal structure of the complex between thrombin and the central "E" region of fibrin. Proc. Natl. Acad. Sci. USA 101 (2004) 2718-2723
167. Pechik I., Yakovlev S., Mosesson M.W., Gilliland G.L., and Medved L. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. Biochemistry 45 (2006) 3588-3597
168. Perona J.J., and Craik C.S. Structural basis of substrate specificity in the serine proteases. Protein Sci. 4 (1995) 337-360
169. Perona J.J., and Craik C.S. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J. Biol. Chem. 272 (1997) 29987-29990
170. Petrovan R.J., and Ruf W. Role of residue Phe225 in the cofactor-mediated, allosteric regulation of the serine protease coagulation factor VIIa. Biochemistry 39 (2000) 14457-14463
171. Pineda A.O., Cantwell A.M., Bush L.A., Rose T., and Di Cera E. The thrombin epitope recognizing thrombomodulin is a highly cooperative hot spot in exosite I. J. Biol. Chem. 277 (2002) 32015-32019
172. Pineda A.O., Savvides S.N., Waksman G., and Di Cera E. Crystal structure of the anticoagulant slow form of thrombin. J. Biol. Chem. 277 (2002) 40177-40180
173. + binding to thrombin. J. Biol. Chem. 279 (2004) 31842-31853
174. Pineda A.O., Chen Z.W., Caccia S., Cantwell A.M., Savvides S.N., Waksman G., Mathews F.S., and Di Cera E. The anticoagulant thrombin mutant W215A/E217A has a collapsed primary specificity pocket. J. Biol. Chem. 279 (2004) 39824-39828
175. Pineda A.O., Zhang E., Guinto E.R., Savvides S.N., Tulinsky A., and Di Cera E. Crystal structure of the thrombin mutant D221A/D222K: the Asp222:Arg187 ion-pair stabilizes the fast form. Biophys. Chem. 112 (2004) 253-256
176. Pineda A.O., Chen Z.W., Bah A., Garvey L.C., Mathews F.S., and Di Cera E. Crystal structure of thrombin in a self-inhibited conformation. J. Biol. Chem. 281 (2006) 32922-32928
177. Pineda A.O., Chen Z.W., Marino F., Mathews F.S., Mosesson M.W., and Di Cera E. Crystal structure of thrombin in complex with fibrinogen gamma' peptide. Biophys. Chem. 125 (2007) 556-559
178. Prasad S., Wright K.J., Roy D.B., Bush L.A., Cantwell A.M., and Di Cera E. Redesigning the monovalent cation specificity of an enzyme. Proc. Natl. Acad. Sci. USA 100 (2003) 13785-13790
179. Prasad S., Cantwell A.M., Bush L.A., Shih P., Xu H., and Di Cera E. Residue Asp-189 controls both substrate binding and the monovalent cation specificity of thrombin. J. Biol. Chem. 279 (2004) 10103-10108
180. Ramakrishnan V., DeGuzman F., Bao M., Hall S.W., Leung L.L., and Phillips D.R. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc. Natl. Acad. Sci. USA 98 (2001) 1823-1828
181. Rawlings N.D., Tolle D.P., and Barrett A.J. MEROPS: the peptidase database. Nucleic Acids Res. 32 Database issue (2004) D160-D164
182. Rezaie A.R., and Esmon C.T. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J. Biol. Chem. 267 (1992) 26104-26109
183. Rezaie A.R., and He X. Sodium binding site of factor Xa: role of sodium in the prothrombinase complex. Biochemistry 39 (2000) 1817-1825
184. + and factor Va in the prothrombinase complex. J. Biol. Chem. 279 (2004) 48262-48269
185. Rezaie A.R., and Olson S.T. Contribution of lysine 60f to S1' specificity of thrombin. Biochemistry 36 (1997) 1026-1033
186. Rezaie A.R., and Yang L. Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Proc. Natl. Acad. Sci. USA 100 (2003) 12051-12056
187. Richardson M.A., Gerlitz B., and Grinnell B.W. Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant. Nature 360 (1992) 261-264
188. 2+: molecular determinants and functional consequences. Physiol. Rev. 86 (2006) 369-408
189. Rose T., and Di Cera E. Three-dimensional modeling of thrombin-fibrinogen interaction. J. Biol. Chem. 277 (2002) 18875-18880
190. + channel: electrostatic stabilization of monovalent cations. Science 285 (1999) 100-102
191. Rouy S., Vidaud D., Alessandri J.L., Dautzenberg M.D., Venisse L., Guillin M.C., and Bezeaud A. Prothrombin Saint-Denis: a natural variant with a point mutation resulting in Asp to Glu substitution at position 552 in prothrombin. Br. J. Haematol. 132 (2006) 770-773
192. + binding. Proteins 43 (2001) 315-318
193. Rubin D., and Christian C. Retinal hemorrhages in infants with hyponatremic seizures. Pediatr. Emerg. Care 17 (2001) 313-314
194. Rydel T.J., Tulinsky A., Bode W., and Huber R. Refined structure of the hirudin-thrombin complex. J. Mol. Biol. 221 (1991) 583-601
195. Sadasivan C., and Yee V.C. Interaction of the factor XIII activation peptide with alpha-thrombin. Crystal structure of its enzyme-substrate analog complex. J. Biol. Chem. 275 (2000) 36942-36948
196. Sambrano G.R., Weiss E.J., Zheng Y.W., Huang W., and Coughlin S.R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413 (2001) 74-78
197. Scatena M., Liaw L., and Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2302-2309
198. Scharer K., Morgenthaler M., Paulini R., Obst-Sander U., Banner D.W., Schlatter D., Benz J., Stihle M., and Diederich F. Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of factor Xa bound to a quaternary ammonium ion ligand. Angew. Chem. Int. Ed. Engl. 44 (2005) 4400-4404
199. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
200. 2+ site in the protease domain of human activated protein C (APC). Sodium ion in the APC crystal structure is coordinated to four carbonyl groups from two separate loops. J. Biol. Chem. 277 (2002) 28987-28995
201. + site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding. J. Mol. Biol. 350 (2005) 78-91
202. Schreiber G., and Fersht A.R. Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. J. Mol. Biol. 248 (1995) 478-486
203. Seeley S., Covic L., Jacques S.L., Sudmeier J., Baleja J.D., and Kuliopulos A. Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding. Chem. Biol. 10 (2003) 1033-1041
204. Shapiro M.J., Weiss E.J., Faruqi T.R., and Coughlin S.R. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J. Biol. Chem. 275 (2000) 25216-25221
205. Sheehan J.P., and Sadler J.E. Molecular mapping of the heparin-binding exosite of thrombin. Proc. Natl. Acad. Sci. USA 91 (1994) 5518-5522
206. Sprang S., Standing T., Fletterick R.J., Stroud R.M., Finer-Moore J., Xuong N.H., Hamlin R., Rutter W.J., and Craik C.S. The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. Science 237 (1987) 905-909
207. Stanchev h., Philips M., Villoutreix B.O., Aksglaede L., Lethagen S., and Thorsen S. Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency. Thromb. Haemost. 95 (2006) 195-198
208. Steiner S.A., and Castellino F.J. Kinetic studies of the role of monovalent cations in the amidolytic activity of activated bovine plasma protein C. Biochemistry 21 (1982) 4609-4614
209. Steiner S.A., and Castellino F.J. Effect of monovalent cations on the pre-steady-state kinetic parameters of the plasma protease bovine activated protein C. Biochemistry 24 (1985) 1136-1141
210. Steiner S.A., and Castellino F.J. Kinetic mechanism for stimulation by monovalent cations of the amidase activity of the plasma protease bovine activated protein C. Biochemistry 24 (1985) 609-617
211. Steiner S.A., Amphlett G.W., and Castellino F.J. Stimulation of the amidase and esterase activity of activated bovine plasma protein C by monovalent cations. Biochem. Biophys. Res. Commun. 94 (1980) 340-347
212. Stevens R.C., Chook Y.M., Cho C.Y., Lipscomb W.N., and Kantrowitz E.R. Escherichia coli aspartate carbamoyltransferase: the probing of crystal structure analysis via site-specific mutagenesis. Protein Eng. 4 (1991) 391-408
213. Stubbs M.T., Oschkinat H., Mayr I., Huber R., Angliker H., Stone S.R., and Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur. J. Biochem. 206 (1992) 187-195
214. Suelter C.H. Enzymes activated by monovalent cations. Science 168 (1970) 789-795
215. Suh T.T., Holmback K., Jensen N.J., Daugherty C.C., Small K., Simon D.I., Potter S., and Degen J.L. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9 (1995) 2020-2033
216. Sun W.Y., Witte D.P., Degen J.L., Colbert M.C., Burkart M.C., Holmback K., Xiao Q., Bugge T.H., and Degen S.J. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc. Natl. Acad. Sci. USA 95 (1998) 7597-7602
217. Sun W.Y., Burkart M.C., Holahan J.R., and Degen S.J. Prothrombin San Antonio: a single amino acid substitution at a factor Xa activation site (Arg320 to His) results in dysprothrombinemia. Blood 95 (2000) 711-714
218. + (LYS-556 to THR) leads to dysprothrombinemia. Thromb. Haemost. 85 (2001) 651-654
219. Tainer J.A., Roberts V.A., and Getzoff E.D. Protein metal-binding sites. Curr. Opin. Biotechnol. 3 (1992) 378-387
220. Tauszig S., Jouanguy E., Hoffmann J.A., and Imler J.L. Toll-related receptors and the control of antimicrobial peptide expression in drosophila. Proc. Natl. Acad. Sci. USA 97 (2000) 10520-10525
221. Taylor F.B., Chang A., Esmon C.T., D'Angelo A., Vigano-D'Angelo S., and Blick K.E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J. Clin. Invest. 79 (1987) 918-925
222. Taylor Jr. F.B., Peer G.T., Lockhart M.S., Ferrell G., and Esmon C.T. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 97 (2001) 1685-1688
223. Tollefsen D.M. Heparin cofactor II modulates the response to vascular injury. Arterioscler. Thromb. Vasc. Biol. (2006)
224. Tsiang M., Jain A.K., Dunn K.E., Rojas M.E., Leung L.L., and Gibbs C.S. Functional mapping of the surface residues of human thrombin. J. Biol. Chem. 270 (1995) 16854-16863
225. Tsiang M., Paborsky L.R., Li W.X., Jain A.K., Mao C.T., Dunn K.E., Lee D.W., Matsumura S.Y., Matteucci M.D., Coutre S.E., et al. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry 35 (1996) 16449-16457
226. Tsiang M., Jain A.K., and Gibbs C.S. Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin. J. Biol. Chem. 272 (1997) 12024-12029
227. Turner G.J., Galacteros F., Doyle M.L., Hedlund B., Pettigrew D.W., Turner B.W., Smith F.R., Moo-Penn W., Rucknagel D.L., and Ackers G.K. Mutagenic dissection of hemoglobin cooperativity: effects of amino acid alteration on subunit assembly of oxy and deoxy tetramers. Proteins 14 (1992) 333-350
228. 2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding. J. Biol. Chem. 275 (2000) 36876-36884
229. van de Locht A., Bode W., Huber R., Le Bonniec B.F., Stone S.R., Esmon C.T., and Stubbs M.T. The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin. EMBO J. 16 (1997) 2977-2984
230. van Holde K.E. A hypothesis concerning diffusion-limited protein-ligand interactions. Biophys. Chem. 101-102 (2002) 249-254
231. Vijayalakshmi J., Padmanabhan K.P., Mann K.G., and Tulinsky A. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci. 3 (1994) 2254-2271
232. Vindigni A., and Di Cera E. Release of fibrinopeptides by the slow and fast forms of thrombin. Biochemistry 35 (1996) 4417-4426
233. Vindigni A., White C.E., Komives E.A., and Di Cera E. Energetics of thrombin-thrombomodulin interaction. Biochemistry 36 (1997) 6674-6681
234. Vu T.K., Wheaton V.I., Hung D.T., Charo I., and Coughlin S.R. Domains specifying thrombin-receptor interaction. Nature 353 (1991) 674-677
235. Wells J.A. Additivity of mutational effects in proteins. Biochemistry 29 (1990) 8509-8517
236. Wells C.M., and Di Cera E. Thrombin is a Na(+)-activated enzyme. Biochemistry 31 (1992) 11721-11730
237. Wilbanks S.M., and McKay D.B. How potassium affects the activity of the molecular chaperone Hsc70. II. Potassium binds specifically in the ATPase active site. J. Biol. Chem. 270 (1995) 2251-2257
238. Wilbanks S.M., and McKay D.B. Structural replacement of active site monovalent cations by the epsilon-amino group of lysine in the ATPase fragment of bovine Hsc70. Biochemistry 37 (1998) 7456-7462
239. Workman E.F., and Lundblad R.L. The effect of monovalent cations on the catalytic activity of thrombin. Arch. Biochem. Biophys. 185 (1978) 544-548
240. Wu Q.Y., Sheehan J.P., Tsiang M., Lentz S.R., Birktoft J.J., and Sadler J.E. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. Proc. Natl. Acad. Sci. USA 88 (1991) 6775-6779
241. Xue J., Wu Q., Westfield L.A., Tuley E.A., Lu D., Zhang Q., Shim K., Zheng X., and Sadler J.E. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc. Natl. Acad. Sci. USA 95 (1998) 7603-7607
242. Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A., Gilbert T., Davie E.W., and Foster D.C. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. USA 95 (1998) 6642-6646
243. Xu H., Bush L.A., Pineda A.O., Caccia S., and Di Cera E. Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. J. Biol. Chem. 280 (2005) 7956-7961
244. + binding. J. Biol. Chem. 279 (2004) 38519-38524
245. Yang L., Manithody C., and Rezaie A.R. Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc. Natl. Acad. Sci. USA 103 (2006) 879-884
246. Ye J., Esmon N.L., Esmon C.T., and Johnson A.E. The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J. Biol. Chem. 266 (1991) 23016-23021
247. Yun T.H., Baglia F.A., Myles T., Navaneetham D., Lopez J.A., Walsh P.N., and Leung L.L. Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively. J. Biol. Chem. 278 (2003) 48112-48119
248. Zhang B., and Ginsburg D. Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders. J. Thromb. Haemost. 2 (2004) 1564-1572
249. + binding site of thrombin. Biophys. Chem. 63 (1997) 185-200